Cerebral computed tomography showed a minor cerebral infarction. Serum concentrations of IgG anticardiolipin antibodies were increased (>40 U, normal <3 U), and APTT prolonged (42 s, normal <35 s). An extensive investigation of the coagulation system showed that the patient had normal levels of coagulation factors, but that an anticoagulant was present in the IgG fraction of plasma. She was treated with corticosteroids (prednisolone 5-10 mg/day), azathioprine (200-100 mg/day), low dosage acetylsalicylic acid, and antihypertensive drugs (metoprolol) until the present event.
In June 1988 the patient presented with thrombocytopenia (5-lOx l09 platelets/l), prolonged APTT (134 s), and high concentrations of IgG anticardiolipin antibodies (>40 U). Bone marrow smears showed the cell morphology to be normal. Treatment with prednisolone (50-100 mg/day) during the following weeks in combination with intermittent oral cyclophosphamide (500 mg, five courses with one to two week intervals) was unsuccessful. The platelet count remained at 5-20x 109/1 and IgG anticardiolipin antibody concentrations high (>40 U). In early August the patient developed an acute stroke with paresis of the right arm. With computed tomography a lacunar infarction was detected in the left hemisphere. The blood pressure was normal (120/70 mmHg). Echocardiography was normal. The cyclophosphamide was withdrawn, but corticosteroid treatment continued (prednisolone 75 mg/day), now in combination with chlorambucil (4-8 mg/day) and plasmapheresis. Response was poor, however; the platelet count remained low (10-30x 109/l) even after four weeks of treatment, and thus effective anticoagulant treatment still could not be given.
In view of the poor response to the latter regimen it was decided to give a course of intravenous gammaglobulin. At this stage coagulation studies now showed prothrombin 9 There is no doubt about the need for new, less risky treatment regimens for use in these disorders. We suggest that the treatment described here might be considered in severe cases of the antiphospholipid syndrome with concomitant thrombocytopenia and thrombotic processes, especially when other active manifestations of SLE are present. Complications following intravenous immunoglobulin infusions are rare, though septic infection niay occur. Drawbacks, restricting the use of this treatment to selected and severe cases, are the high cost and the need for intravenous administration. 
